Literature DB >> 6177989

A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody.

J O McGee, J C Woods, F Ashall, M E Bramwell, H Harris.   

Abstract

The Ca1 antibody has been used in an immunohistochemical procedure to detect the Ca antigen in sections of tissues routinely embedded in paraffin wax. A representative sample of benign and malignant tumours from all the systems of the human body has been examined. The majority of malignant tumors express the Ca antigen. The exceptions are: prostatic carcinomas, testicular teratocarcinomas and seminomas, some sarcomas, some lymphomas, malignant brain tumours, neuroblastomas, and melanomas. The antigen is least readily detected in epithelial malignancies of the alimentary system, particularly of the colon. The Ca1 antibody does not react with any benign tumour. The only normal tissues that react specificity with this antibody are the epithelium of the fallopian tube and the transitional epithelium of the urinary tract. The Ca1 antibody also readily distinguishes malignant cells in smears of malignant effusions. These findings indicate that the Ca1 antibody may be useful in the diagnosis of malignancy in routine clinical practice where the morphological interpretation of the biopsy or cytological smear is in doubt.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177989     DOI: 10.1016/s0140-6736(82)91151-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

Review 1.  Distribution of epithelial antigens in the human uterine cervix: a review.

Authors:  V Serra; A Ramirez; M C Marzo; F Valcuende; C Lara; A Castells; F Bonilla-Musoles
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Ca antigen and urothelial antibacterial defences: hypothesis.

Authors:  J A Morris; K Oates; W G Staff
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

3.  Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.

Authors:  J Steffens; W Friedmann; H Lobeck
Journal:  Urol Res       Date:  1985

4.  Epithelial membrane antigen in cells from the uterine cervix: immunocytochemical staining of cervical smears.

Authors:  B Valkova; M G Ormerod; D Moncrieff; D V Coleman
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

5.  Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.

Authors:  A K Ghosh; D Y Mason; A I Spriggs
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

6.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.

Authors:  H Koho; S Paulie; H Ben-Aissa; I Jónsdóttir; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma.

Authors:  R Mariani-Costantini; M I Colnaghi; F Leoni; S Mènard; S Cerasoli; F Rilke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Distribution of the Ca (Oxford) antigen in lung neoplasms and non-neoplastic lung tissues.

Authors:  F J Paradinas; G Boxer; K D Bagshawe
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

9.  Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes.

Authors:  J Fischer; P J Klein; G H Farrar; F G Hanisch; G Uhlenbruck
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

10.  Monoclonal antibodies against antigens on breast cancer cells.

Authors:  C Stähli; B Takacs; V Miggiano; T Staehelin; H Carmann
Journal:  Experientia       Date:  1985-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.